|
GLG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.598500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.918400E-01 |
| Normal-vs-Stage2 |
2.623800E-03 |
| Normal-vs-Stage3 |
3.583200E-04 |
| Normal-vs-Stage4 |
7.90260000000931E-05 |
| Stage1-vs-Stage2 |
2.244500E-03 |
| Stage1-vs-Stage3 |
1.785720E-04 |
| Stage1-vs-Stage4 |
5.71129999999975E-05 |
| Stage2-vs-Stage3 |
7.968400E-01 |
| Stage2-vs-Stage4 |
7.287000E-01 |
| Stage3-vs-Stage4 |
4.747600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.197760E-02 |
| Normal-vs-AfricanAmerican |
4.446500E-02 |
| Normal-vs-Asian |
7.934000E-01 |
| Caucasian-vs-AfricanAmerican |
4.953000E-01 |
| Caucasian-vs-Asian |
3.391000E-01 |
| AfricanAmerican-vs-Asian |
2.789200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.031400E-04 |
| Normal-vs-Female |
4.387600E-01 |
| Male-vs-Female |
8.623900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.621000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.508000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.626900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.375200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.385600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.968400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.542200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.660200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.496800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.298200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.376300E-02 |
| Normal-vs-Grade 2 |
3.728800E-01 |
| Normal-vs-Grade 3 |
1.335900E-03 |
| Normal-vs-Grade 4 |
3.75759999999836E-05 |
| Grade 1-vs-Grade 2 |
9.521900E-03 |
| Grade 1-vs-Grade 3 |
7.170800E-04 |
| Grade 1-vs-Grade 4 |
1.86764999999811E-05 |
| Grade 2-vs-Grade 3 |
8.976900E-03 |
| Grade 2-vs-Grade 4 |
5.566700E-04 |
| Grade 3-vs-Grade 4 |
1.504010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.821600E-01 |
| Normal-vs-ccB subtype |
1.680490E-03 |
| ccA subtype-vs-ccB subtype |
3.753100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.282200E-02 |
| Normal-vs-N1 |
8.479100E-03 |
| N0-vs-N1 |
3.002000E-01 |
|
|
